New Opportunity Expansion?






Get back in your cubicle you Ann Arbor hack!! This place blows!! Try spending a day in the field sometime.
I enjoy it, it can be challenging at times. We are gaining more favorable perceptions with outcomes data, and it’s helping drive more business. This is never going to be a Lipitor, but there is plenty of room for expanded usage now that patients are more brand aware thanks to NASCAR, and physicians comfort and confidence levels increase. This is not a good fit for people who want to go out and “represent” a product, it must be sold through strong clinical knowledge, confidence and conviction.
 


I enjoy it, it can be challenging at times. We are gaining more favorable perceptions with outcomes data, and it’s helping drive more business. This is never going to be a Lipitor, but there is plenty of room for expanded usage now that patients are more brand aware thanks to NASCAR, and physicians comfort and confidence levels increase. This is not a good fit for people who want to go out and “represent” a product, it must be sold through strong clinical knowledge, confidence and conviction.

Yep the NASCAR rednecks are bearing the doctor offices door down. The Circle Tracking Crowd are nothing but a pimple on the ass of lipid therapy. No office has seen strong clinical knowledge and selling skills. The office I work in laugh at the Esperion clown who comes in bragging how the race car did in a race I've never heard. As for the data nobody was impressed as the stock price reflected this when results came out. Thankfully your co- market with DS is going to wither away when you lose your court case. This is a company of losers!
 


Yep the NASCAR rednecks are bearing the doctor offices door down. The Circle Tracking Crowd are nothing but a pimple on the ass of lipid therapy. No office has seen strong clinical knowledge and selling skills. The office I work in laugh at the Esperion clown who comes in bragging how the race car did in a race I've never heard. As for the data nobody was impressed as the stock price reflected this when results came out. Thankfully your co- market with DS is going to wither away when you lose your court case. This is a company of losers!
You’re angry, Karen. Looks like you had another lonely holiday.
 


What company would hang their clinical efficacy on how a stock car is doing? What a stupid marketing idea to start with. Those southerners have no idea what the name of this drug is or what it does? Great waste of money.
 






Yep the NASCAR rednecks are bearing the doctor offices door down. The Circle Tracking Crowd are nothing but a pimple on the ass of lipid therapy. No office has seen strong clinical knowledge and selling skills. The office I work in laugh at the Esperion clown who comes in bragging how the race car did in a race I've never heard. As for the data nobody was impressed as the stock price reflected this when results came out. Thankfully your co- market with DS is going to wither away when you lose your court case. This is a company of losers!

Yes. The Race Car marketing was brilliant. Lol
 












Esperion has a number of Field openings.

I bet they double down on the Scientific Hiring Process. Lol

It did create " A highly Tenured Customer Facing Team, and Lipid Trained Experts". Lol

So where did the first team go ? Lol

What a culture.
 


I’m in the process right now and it seems like it could be a pretty good opportunity, I’m just not sure exactly how they’re going to proceed forward. The information I’ve gotten thus far has been a bit vague, interviews have gone well, but I’ve not been able to pin down much info on how the process forward looks and the timelines. Does anyone else have any insight?
 


I’m in the process right now and it seems like it could be a pretty good opportunity, I’m just not sure exactly how they’re going to proceed forward. The information I’ve gotten thus far has been a bit vague, interviews have gone well, but I’ve not been able to pin down much info on how the process forward looks and the timelines. Does anyone else have any insight?

You don't know " How they are going to proceed forward ".

"Information vague "

"I"ve not been able to pin down much info on how the process forward looks and the timelines"

Read your own post !!!!

Wow !
 






You are welcome for thanking me for my input.

No need to get negative.

Karen label.

Shop worn.

Anything else ?
More of your finance and scientific pontifications, please, Karen. What are your PTRS projections for tafolecimab and its impact on the non-FH market 10-yr CAGR based upon the phase 3 trial outcomes? Should any organization look at a licensing deal or perhaps acquire the asset? Can you get us a dossier from one of your HEOR connections? What were the endpoints that drove HTA to cover it or even the MOH in Brazil? That would help with CMS and peri-launch access strategy. Please share, Karen. Your basic business administration stock trading tips have been gold.
 



Write your reply...